Replies to post #71887 on Anavex Life Sciences Corp (AVXL)

[tdtcal]

Impediment mine most assuredly. Appreciate your patience.

Now about reasonable. There was a new antibiotic "chemical" that was discovered a few years ago. Never in clinical trials but as it was a potential new "family" of antibiotic was sold for about 1 billion to the pharmaceutical chemist and his group.

As 100 million is usually paid out in tranches, the risk is lowered considerably (and so is the dollar amount) particularly when as each test milestone is met additional investors pile on. Conversely if a milestone isn't met, the payments stop.

Governments are large payers for drugs. They dread diseases that chronically incapacitate people. They will be more agreeable to subsidize a drug that stabilizes a person and keeps them out of nursing homes - which they subsidize as well.

Probably why there have been so many Phase 3 trials at all.

[XenaLives]

A non-sequitur... only AVXL data applies.

[McMagyar]

YOU MUST BE KIDDING? $100 Million is NOTHING!
BP Spits that out with Shrimp Guts everyday..
Anavex has Research Value ALONE of MORE than $500,000,000 ....


Any License Deal is in the BILLIONS with Hundreds of MILLIONS upfront to anavex

DID YOU see the Montherapy Data?
LOOKS like 100 % of One Arm Monotherapy saw Curative Effect over 6 months..
when they ALL would have/should have fallen by 4-6 Points..
$100,000 ,000 for a Business that is worth 10's of billions EVERY YEAR?

will not let loose how I realy feel..